Form 4: ClearPoint Neuro Director Acquires Shares

ClearPoint Neuro Director Pascal Girin acquired 502 shares of common stock at $13.68 per share as part of a compensation plan.

Summary

• Director Pascal E. R. Girin acquired 502 shares of ClearPoint Neuro, Inc. common stock.
• The transaction occurred on January 2, 2026, and was made pursuant to a Rule 10b5-1 plan.
• The shares were acquired at a price of $13.68 per share.
• Following this transaction, Mr. Girin beneficially owns 97,451 shares of common stock.
• The acquisition was made pursuant to the company's Sixth Amended and Restated 2013 Incentive Compensation Plan.
• These shares represent payment for fees owed to Mr. Girin under the Non-Employee Director Compensation Plan, as amended and restated.
• The shares were issued at the closing price of the issuer's common stock on December 31, 2025.

Sentiment

Score: 7

Explanation: The acquisition of shares by a director, even as part of a compensation plan, generally indicates alignment of interests and a degree of confidence in the company's future. It's a routine, positive signal, but not a major market mover.

Positives

• A director increasing their stake in the company, even through compensation, can signal confidence in future performance and aligns their interests with shareholders.
• The transaction is part of a pre-existing, transparent compensation plan (Rule 10b5-1 and Incentive Compensation Plan), indicating structured corporate governance.

Future Outlook

The filing does not contain specific forward-looking statements or guidance beyond the future transaction date, which is part of a pre-planned arrangement.

Industry Context

This Form 4 filing is a routine insider transaction report and does not provide broader industry context or trends. It reflects an individual director's compensation and equity holdings within ClearPoint Neuro, Inc., which is a common practice across publicly traded companies.

Comparison to Industry Standards

• This filing reports a standard equity compensation transaction for a non-employee director, consistent with common corporate governance practices across various industries.
• The use of an Incentive Compensation Plan and a Non-Employee Director Compensation Plan for equity awards is a widely adopted method for aligning director interests with shareholders, similar to practices seen in companies like Medtronic or Stryker in the medical technology sector, though the specific values are company-specific.

Corporate Governance

Related Party Transactions

• Director Pascal E. R. Girin, a related party, acquired shares from ClearPoint Neuro, Inc. as compensation for services, which is a common form of related party transaction under established compensation plans.

Stakeholder Impact

• Shareholders: Increased alignment of the director's interests with shareholders through equity ownership, potentially fostering better long-term decision-making.
• Employees: No direct impact on employees is mentioned in this filing.
• Customers: No direct impact on customers is mentioned in this filing.
• Suppliers: No direct impact on suppliers is mentioned in this filing.
• Creditors: No direct impact on creditors is mentioned in this filing.

Key Dates

Recommendation

This Form 4 filing reports a routine insider transaction where a director received shares as part of their compensation plan. While it indicates alignment of interests, it does not present new information significant enough to warrant a change in investment recommendation. It's a standard, expected event that doesn't fundamentally alter the company's investment thesis or immediate valuation.

Keywords

ClearPoint Neuro, CLPT, Form 4, Insider Transaction, Director Share Acquisition, Equity Compensation, Pascal Girin, Beneficial Ownership, 10b5-1 Plan